Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer-Combination Strategies.
Daria ArbuznikovaMatthias EderAnca-Ligia GrosuPhilipp T MeyerChristian GratzkeConstantinos ZamboglouAnn-Christin EderPublished in: Current oncology reports (2023)
Lu]Lu-PSMA-617 and immune checkpoint inhibition for late-stage prostate cancer.